The Fund'’s investment objective is to replicate closely a large, actively managed, UK-based private client portfolio seeking long-term capital growth whilst providing a moderate level of income.
Name | % Net Assets |
---|---|
Cazenove European Equity | 10.5% |
Dexion Absolute | 9.5% |
FINDLAY PARK AMERICAN SMALLER COMPANIES | 7.5% |
M&G OPTIMAL INCOME | 6.2% |
CF WALKER CRIPS UK GROWTH | 6.1% |
INVESCO PERP INCOME | 6.1% |
GARTMORE FUND MANAGERS US GROWTH RETAIL CLS`A` NAV | 5.3% |
GLG PARTNERS INVESTMENT FUNDS LTD JAPAN COREALPHA | 3.7% |
CAZENOVE EUROPEAN EX UK EQUITY | 3.7% |
INVESTEC FUND MANAGERS UK SPECIAL SITUATIONS FUND | 3.7% |
Key | % Net Assets |
---|---|
Cazenove European Equity | 10.5% |
Dexion Absolute | 9.5% |
FINDLAY PARK AMERICAN SMALLER COMPANIES | 7.5% |
M&G OPTIMAL INCOME | 6.2% |
Other | 66.3% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 18/02/2000 |
---|---|
Fund Manager | Anne West |
TER | 1.64 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | 1000000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.11 |
You are here: research